This study discovered a potential mechanism of how pulmonary fibrosis develops using a micro-engineered tissue model. This is important because this powerful tool can now be used to test and develop anti-fibrosis drugs for pulmonary fibrosis, which is often fatal. Senior author Ruogang Zhao received a Lung Association Innovation Award to develop experimental models to screen anti-fibrosis drugs.
This November, your gift will help fund lifesaving lung disease research—and will be 2X matched, up to $50,000, thanks to a generous family foundation.
Join over 700,000 people who receive the latest news about lung health, including research, lung disease, air quality, quitting tobacco, inspiring stories and more!
Thank you! You will now receive email updates from the American Lung Association.